Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
610.93B
Market cap610.93B
Price-Earnings ratio
37.71
Price-Earnings ratio37.71
Dividend yield
2.12%
Dividend yield2.12%
Average volume
8.11M
Average volume8.11M
High today
$253.81
High today$253.81
Low today
$248.60
Low today$248.60
Open price
$249.10
Open price$249.10
Volume
5.60M
Volume5.60M
52 Week high
$281.07
52 Week high$281.07
52 Week low
$184.66
52 Week low$184.66

Stock Snapshot

With a market cap of 610.93B, Johnson & Johnson(JNJ) trades at $253.51. The stock has a price-to-earnings ratio of 37.71 and currently yields dividends of 2.12%.

As of 2026-10-14, Johnson & Johnson(JNJ) stock has fluctuated between $248.60 and $253.81. The current price stands at $253.51, placing the stock +2.0% above today's low and -0.1% off the high.

The Johnson & Johnson(JNJ)'s current trading volume is 5.6M, compared to an average daily volume of 8.11M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $281.07 and a 52-week low of $184.66.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $281.07 and a 52-week low of $184.66.

JNJ News

Benzinga 1h
Johnson & Johnson Q3 Sets 'Negative Tone For Broader Pharma Sector': Analysts

Shares of Johnson & Johnson (NYSE:JNJ) rose in early trading on Wednesday, after the company reported upbeat third-quarter results. Here are some key analyst t...

Johnson & Johnson Q3 Sets 'Negative Tone For Broader Pharma Sector': Analysts
Benzinga 2h
These Analysts Cut Their Forecasts On Johnson & Johnson After Q3 Results

Johnson & Johnson (NYSE:JNJ) on Tuesday reported upbeat third-quarter results and raised its full-year guidance. Adjusted earnings fell 7.5% year over year to...

These Analysts Cut Their Forecasts On Johnson & Johnson After Q3 Results
24/7 Wall St. 5h
The 3-Bucket Income System Making $13,000/Month in Pure Dividends

Personal Finance The 3-Bucket Income System Making $13,000/Month in Pure Dividends Most investors chase the highest yield they can find, but that single decisio...

The 3-Bucket Income System Making $13,000/Month in Pure Dividends

Analyst ratings

70%

of 27 ratings
Buy
70.4%
Hold
22.2%
Sell
7.4%

More JNJ News

Benzinga 6h
Stock of the Day: Is this the Bottom for Johnson & Johnson?

Trading in Johnson & Johnson (NYSE:JNJ) is quiet Wednesday. The shares dropped by almost 6% yesterday after the company reported its earnings. As you can see on...

Stock of the Day: Is this the Bottom for Johnson & Johnson?
TipRanks 6h
Johnson & Johnson price target lowered to $280 from $290 at RBC Capital

RBC Capital lowered the firm’s price target on Johnson & Johnson to $280 from $290 and keeps an Outperform rating on the shares. The stock’s 6% decline after in...

BBC 7h
Family pays tribute to 'warm and engaging' man killed in tiger attack - BBC

...

Family pays tribute to 'warm and engaging' man killed in tiger attack - BBC
Zacks 8h
JNJ Q3 Earnings Call Highlights Growth Outlook and MedTech Challenges

Johnson & Johnson (JNJ Quick QuoteJNJ - Free Report) used its third-quarter 2026 earnings call to raise the full-year guidance following stronger growth i...

JNJ Q3 Earnings Call Highlights Growth Outlook and MedTech Challenges
TipRanks 9h
J&J Buy Rating Reiterated as Long-Term Pipeline Strength Supports Outlook; $294 Price Target Unchanged

Morgan Stanley analyst Terence Flynn maintained a Buy rating on Johnson & Johnson yesterday and set a price target of $294.00. Terence Flynn has given his Buy r...

TipRanks 9h
Johnson & Johnson price target raised to $270 from $261 at Bernstein

Bernstein raised the firm’s price target on Johnson & Johnson to $270 from $261 and keeps a Market Perform rating on the shares. The firm notes J&J reported a s...

TipRanks 19h
Johnson & Johnson Earnings Call: Growth Amid Headwinds

Johnson & Johnson ((JNJ)) has held its Q3 earnings call. Read on for the main highlights of the call. Johnson & Johnson’s latest earnings call struck a cautious...

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.